OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...

Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...

Altman and Musk were OpenAI’s founding co-chairs in 2015, but their relationship has devolved into name-calling and lawsuits.

Cathie Wood and her Ark Invest funds sold Oklo — the nuclear power startup backed by OpenAI head Sam Altman — and purchased ...

In the latest development in the pair’s longtime feud, Elon Musk, a key White House advisor as well as the founder of AI ...

Earlier this week, he unveiled perhaps the most ambitious infrastructure project in history—and all but dedicated it to Sam ...

President Trump's massive $500 billion AI infrastructure dubbed Stargate rustled plenty of feathers, reigniting a bitter feud ...

Retro Biosciences Inc., a startup using artificial intelligence to discover new drugs, is reportedly raising $1 billion in ...

Sam Altman Reveals Exciting Big News on X: ChatGPT’s Free Tier Will Get o3-mini Access, While Plus Tier Users to Get Tons of ...

OpenAI CEO Sam Altman envisions a future where AI surpasses human intelligence, emphasizing that human skills will still hold ...

Stargate is little more than an extension of Sam Altman's powerful AI company, anonymous sources told the Financial Times.

Musk has raised questions on project Stargate, the $500bn AI project. This lead to a verbal spat between him and Sam Altman.